| 000 | 01590 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515095945.0 | ||
| 264 | 0 | _c20080307 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a0886-022X | ||
| 024 | 7 |
_a10.1080/08860220701641579 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSikole, Aleksandar | |
| 245 | 0 | 0 |
_aTreatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy. _h[electronic resource] |
| 260 |
_bRenal failure _c2007 |
||
| 300 |
_a961-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRenal Dialysis |
| 700 | 1 | _aDzekova, Pavlina | |
| 700 | 1 | _aSelja, Nexhmi | |
| 700 | 1 | _aGaseva, Magdalena | |
| 700 | 1 | _aNikolov, Igor G | |
| 700 | 1 | _aZabzun, Mustafa | |
| 700 | 1 | _aMuharemi, Sheriat | |
| 700 | 1 | _aAsani, Arben | |
| 700 | 1 | _aAmitov, Vili | |
| 700 | 1 | _aMena, Sami | |
| 700 | 1 | _aGrunevska, Violeta | |
| 700 | 1 | _aIvanovski, Ljubomir | |
| 700 | 1 | _aPolenakovic, Momir | |
| 773 | 0 |
_tRenal failure _gvol. 29 _gno. 8 _gp. 961-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/08860220701641579 _zAvailable from publisher's website |
| 999 |
_c17580917 _d17580917 |
||